ISCI Research

Basic Cell Biology, Blood, Bone & Skin, Cancer, Cardiovascular, Diabetes and Nervous System.

Clinical Trials

Clinical Trials

Phase I/II clinical trials testing mesenchymal stem cells (MSC) in cardiology and wound care.


ISCI Leadership

Renowned physician-scientists set a vision for the future of regenerative medicine.

Latest News

Dr. Joshua M. Hare Participates in White House Organ Summit

Joshua M. Hare, M.D., Louis Lemberg Professor of Medicine and Founding Director of the Interdisciplinary Stem Cell Institute (ISCI) at the University of Miami Miller School of Medicine, was among health care professionals, government officials, and industry leaders invited to participate in the White House Organ Summit on June 23.

Read more on the Miller School Web site »

Dr. Jeffrey Goldberger Describes New Precision Therapies for Atrial Fibrillation at Lemberg Lecture

Jeffrey Goldberger, M.D., M.B.A., Chief of the Cardiovascular Division in the Department of Medicine at UHealth - the University of Miami Health System, is working on the development of new precision therapies that could dramatically improve the health outcomes of patients with A-fib. “We are developing potentially groundbreaking technologies,” said Goldberger, who is also a professor of medicine.

Read more on the Miller School Web site »

Miller School’s New Agreement with The Bahamas Will Advance Collaborative Initiatives

A new University of Miami Miller School of Medicine agreement with the government of The Bahamas provides the framework for collaborative initiatives in medical education, research, and clinical care, including stem cells and regenerative medicine. It also advances ongoing discussions about the possibility of establishing a new Miller School-supported medical school in The Bahamas.

Read more on the Miller School Web site »